Gilteritinib hemifumarate
CAS: 1254053-84-3
Ref. 3D-EAC05384
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
Gilteritinib hemifumarate is a bioavailable inhibitor of CTLA-4, which is a receptor for the protein CD80. This protein is expressed on the surface of T cells and plays an important role in regulating the immune system. Gilteritinib hemifumarate has been shown to induce regression in some cancers, such as ovarian cancer, by inhibiting the growth of cancer cells. It also induces apoptosis in leukemia stem cells and monoclonal antibodies that target CD80. This drug binds to CTLA-4 and blocks its inhibitory activity on CD28, which promotes T cell activation.
Propiedades químicas
Consulta técnica sobre: 3D-EAC05384 Gilteritinib hemifumarate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
